Takeda Pharmaceutical Company and the Massachusetts Life Sciences Center (MLSC) have formed a $1 million initiative aimed at supporting women entrepreneurs in early-stage biotech with an eye toward addressing gender gaps in the life sciences sector. The five-year program, called the Massachusetts Next Generation (MassNextGen) Initiative, provides funding and customized support, including mentoring from investors and industry executives, to empower women entrepreneurs and allow them to develop the network and skills necessary to become industry leaders.
Trend toward consolidation evident in merger between Chesapeake IRB and Schulman IRB
In early November, Chesapeake IRB and Schulman IRB merged to form Advarra, a new company designed to leverage mutual strengths in technology, regulatory expertise and customer service. A key goal of the merger is to address the increasingly complex needs associated with research. In fact, the new company was formed as a direct response to customers of the two IRBs, who were looking for an innovative partner to bring them state-of-the-art, superior service.
To read the full articles for this issue of The CenterWatch Weekly, please click here for subscription information.
